NCT02721121

Brief Summary

The purpose of this study is to compare the clinical outcomes depending on catheter ablation strategy for persistent atrial fibrillation. After randomization, investigators will conduct circumferential pulmonary vein isolation alone in a group, and additional posterior box isolation and anterior linear ablation in the other group. Investigators will compare clinical recurrence rate, complication rate, and procedure time, etc.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 28, 2016

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

January 22, 2019

Status Verified

January 1, 2019

Enrollment Period

5 years

First QC Date

March 22, 2016

Last Update Submit

January 18, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recurrence of atrial fibrillation after catheter ablation

    12 month

Secondary Outcomes (3)

  • procedure time

    1 day

  • procedure related complication rate

    12 month

  • rate of hospitalization

    12 month

Study Arms (2)

circumferential pulmonary vein isolation

ACTIVE COMPARATOR

circumferential pulmonary vein isolation

Procedure: circumferential pulmonary vein isolation

Linear ablation in addiction to pulmonary vein isolation

EXPERIMENTAL

Linear ablation in addiction to pulmonary vein isolation

Procedure: Linear ablation in addiction to circumferential pulmonary vein isolation

Interventions

circumferential pulmonary vein isolation
Linear ablation in addiction to pulmonary vein isolation

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with persistent Atrial fibrillation (20\~80 years)
  • LA diameter \<55mm
  • patients possible to anticoagulation and anti arrhythmic drug

You may not qualify if:

  • Structural cardiac disease
  • Contraindication to brain perfusion CT
  • Catheter ablation history for AF,
  • Cardiac surgery for AF
  • active internal bleeding
  • Impossible to anticoagulation or antiarrhythmic drug
  • valvular AF (MA\> GII, Mechanical valve, Mitral valve replacement)
  • Patients with severe medical disease
  • Expected survival \< 1year
  • Severe alcoholics, drug addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance Cardiovascular Hospital, Yonsei University Health System

Seoul, 120-752, South Korea

RECRUITING

Related Publications (1)

  • Lee JM, Shim J, Park J, Yu HT, Kim TH, Park JK, Uhm JS, Kim JB, Joung B, Lee MH, Kim YH, Pak HN; POBI-AF Investigators. The Electrical Isolation of the Left Atrial Posterior Wall in Catheter Ablation of Persistent Atrial Fibrillation. JACC Clin Electrophysiol. 2019 Nov;5(11):1253-1261. doi: 10.1016/j.jacep.2019.08.021. Epub 2019 Oct 30.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2016

First Posted

March 28, 2016

Study Start

March 1, 2016

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

January 22, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations